Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | EFNB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | SCYL1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | FGF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | KCNAB2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
mRNA | ASAP3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | FES | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | TBC1D19 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | IRF6 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
mRNA | ADH5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |